Prognostic significance of occult metastases in colon cancer

被引:47
作者
Merrie, AEH [1 ]
van Rij, AM
Dennett, ER
Phillips, LV
Yun, K
McCall, JL
机构
[1] Univ Otago, Dunedin Sch Med, Dept Surg, Dunedin, New Zealand
[2] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand
[3] Univ Auckland, Fac Hlth Sci, Dept Surg, Auckland 1, New Zealand
关键词
colon cancer; occult metastasis; prognosis; reverse transcription polymerase chain reaction;
D O I
10.1007/s10350-004-6527-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PURPOSE: The purpose of this study was to determine the prognostic significance of occult lymph node metastases in colon cancer detected by cytokeratin 20 reverse transcription polymerase chain reaction. METHODS: Two hundred patients undergoing elective colonic resections were enrolled in the study. Lymph nodes from resected specimens were dissected fresh and assessed by both reverse transcription polymerase chain reaction and histopathology. Follow-up was undertaken for Lip to five years, and the major end point of death was recorded. Univariate survival analysis was performed by, the log-rank method and the change-in-estimate method was used to construct multivariate analysis models for the effect of cytokeratin 20 reverse transcription polymerase chain reaction lymph node status on overall survival. RESULTS: A total of 2,317 lymph nodes from 200 patients were assessed by both histopathology and cytokeratin 20 reverse transcription polymerase chain reaction. Forty-eight of 141 (34 percent) histologically lymph node-negative,e patients had evidence of occult metastases by cytokeratin 20 reverse transcription polymerase chain reaction. Am interim analysis was performed at a median of 42 (range, 23-75) months. Cytokeratin 20 reverse transcription polymerase chain reaction lymph node status was a highly significant predictor of overall survival (P < 0.0001) on univariate analysis. In addition, the number of reverse transcription polymerase chain reaction-positive lymph nodes was a significant predictor of survival in the histologically lymph node-negative group (P < 0.0001) on univariate analysis. On multivariate analysis cytokeratin 20 reverse transcription polymerase chain reaction lymph node status had independent prognostic significance for overall survival (P = 0.021; hazard ratio = 2.7) and the number of cytokeratin 20 reverse transcription polymerase chain reaction-positive lymph nodes was a significant predictor of overall survival in the histologically lymph nodenegative group (P = 0.005; hazard ratio = 1.1 - 11.1). CONCLUSION: Cytokeratin 20 reverse transcription polymerase chain reaction has potential as a clinically useful market for staging colorectal cancer, Further follow-up is required, but if the current trends continue, a study of the effect of adjuvant therapy in patients with occult metastases detected by cytokeratin 20 reverse transcription polymerase chain reaction is indicated.
引用
收藏
页码:221 / 231
页数:11
相关论文
共 54 条
[1]  
Adell G, 1996, EUR J SURG, V162, P637
[2]   Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas - An immunohistochemical study [J].
Broll, R ;
Schauer, V ;
Schimmelpenning, H ;
Strik, M ;
Woltmann, A ;
Best, R ;
Bruch, HP ;
Duchrow, M .
DISEASES OF THE COLON & RECTUM, 1997, 40 (12) :1465-1471
[3]   DETECTION OF EPITHELIAL CANCER-CELLS IN PERIPHERAL-BLOOD BY REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION [J].
BURCHILL, SA ;
BRADBURY, MF ;
PITTMAN, K ;
SOUTHGATE, J ;
SMITH, B ;
SELBY, P .
BRITISH JOURNAL OF CANCER, 1995, 71 (02) :278-281
[4]  
Clarke G, 1997, GUT, V41, pA246
[5]   RESTAGING OF COLORECTAL-CANCER BASED ON THE IDENTIFICATION OF LYMPH-NODE MICROMETASTASES THROUGH IMMUNOPEROXIDASE STAINING OF CEA AND CYTOKERATINS [J].
CUTAIT, R ;
ALVES, VAF ;
LOPES, LC ;
CUTAIT, DE ;
BORGES, JL ;
SINGER, J ;
DASILVA, JH ;
GOFFI, FS .
DISEASES OF THE COLON & RECTUM, 1991, 34 (10) :917-920
[6]  
Denis MG, 1997, INT J CANCER, V74, P540, DOI 10.1002/(SICI)1097-0215(19971021)74:5<540::AID-IJC11>3.0.CO
[7]  
2-A
[8]  
Dorudi S, 1998, BRIT J SURG, V85, P98
[9]   Adjuvant chemotherapy in colorectal carcinoma - Results of a meta-analysis [J].
Dube, S ;
Heyen, F ;
Jenicek, M .
DISEASES OF THE COLON & RECTUM, 1997, 40 (01) :35-41
[10]   THE IDENTIFICATION OF PATIENTS AT HIGH-RISK FOLLOWING CURATIVE RESECTION FOR COLORECTAL-CARCINOMA [J].
FINLAY, IG ;
MCARDLE, CS .
BRITISH JOURNAL OF SURGERY, 1982, 69 (10) :583-584